RENB: Renovaro Biosciences Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Renovaro Biosciences Inc (RENB).
$258.13M Market Cap.
RENB Market Cap. (MRY)
RENB Shares Outstanding (MRY)
RENB Assets (MRY)
Total Assets
$163.13M
Total Liabilities
$31.15M
Total Investments
$0
RENB Income (MRY)
Revenue
$0
Net Income
-$80.65M
Operating Expense
$81.64M
RENB Cash Flow (MRY)
CF Operations
-$10.97M
CF Investing
-$1.26M
CF Financing
$10.52M
RENB Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $163,129,450 (179.81%) | $58,300,796 (-31.11%) | $84,632,663 (-55.36%) | $189,605,225 (6.46%) |
Assets Current | $1,997,643 (-22.13%) | $2,565,405 (-73.18%) | $9,565,138 (-54.23%) | $20,898,993 (133.74%) |
Assets Non-Current | $161,131,807 (189.10%) | $55,735,391 (-25.75%) | $75,067,525 (-55.50%) | $168,706,232 (-0.27%) |
Goodwill & Intangible Assets | $159,360,204 (193.53%) | $54,290,676 (-25.89%) | $73,255,268 (-56.01%) | $166,529,906 (-0.01%) |
Shareholders Equity | $131,977,144 (183.81%) | $46,502,111 (-35.96%) | $72,618,848 (-58.42%) | $174,662,939 (5.05%) |
Property Plant & Equipment Net | $1,751,754 (23.11%) | $1,422,974 (-18.39%) | $1,743,622 (-19.10%) | $2,155,342 (-13.16%) |
Cash & Equivalents | $220,467 (-88.24%) | $1,874,480 (-79.56%) | $9,172,142 (-55.61%) | $20,664,410 (137.62%) |
Accumulated Other Comprehensive Income | -$170,846 (-471.74%) | -$29,882 (1.82%) | -$30,436 (-180.93%) | -$10,834 (73.84%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $1,108,247 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Payables | $9,448,683 (78.38%) | $5,296,823 (277.84%) | $1,401,867 (337.32%) | $320,559 (-45.93%) |
Accumulated Retained Earnings (Deficit) | -$324,679,425 (-33.05%) | -$244,029,253 (-19.42%) | -$204,345,197 (-124.77%) | -$90,911,805 (-41.63%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $3,786,938 (-32.30%) | $5,593,956 (-20.27%) | $7,016,483 (-4.03%) | $7,310,857 (-3.60%) |
Debt Current | $2,944,549 (-38.89%) | $4,818,369 (231.47%) | $1,453,636 (397.12%) | $292,409 (7.79%) |
Debt Non-Current | $842,389 (8.61%) | $775,587 (-86.06%) | $5,562,847 (-20.74%) | $7,018,448 (-4.02%) |
Total Liabilities | $31,152,306 (164.03%) | $11,798,685 (-1.79%) | $12,013,815 (-19.60%) | $14,942,286 (26.31%) |
Liabilities Current | $30,309,917 (174.97%) | $11,023,098 (70.88%) | $6,450,968 (242.06%) | $1,885,893 (41.29%) |
Liabilities Non-Current | $842,389 (8.61%) | $775,587 (-86.06%) | $5,562,847 (-57.39%) | $13,056,393 (24.41%) |
RENB Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $24,557,608 (60.32%) | $15,318,198 (6.90%) | $14,329,801 (89.60%) | $7,557,990 (6.14%) |
Research & Development Expense | $2,708,829 (-34.97%) | $4,165,197 (-50.25%) | $8,372,800 (-46.74%) | $15,720,262 (234.88%) |
Operating Expenses | $81,639,296 (111.74%) | $38,556,891 (-66.78%) | $116,079,191 (396.03%) | $23,401,787 (96.26%) |
Interest Expense | $1,011,322 (74.26%) | $580,344 (55.65%) | $372,844 (-1.78%) | $379,608 (264.03%) |
Income Tax Expense | $0 (0%) | $0 (0%) | $34 (100.03%) | -$125,276 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$80,650,172 (-103.23%) | -$39,684,056 (65.02%) | -$113,433,392 (-324.47%) | -$26,723,607 (-134.08%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$80,650,172 (-103.23%) | -$39,684,056 (65.02%) | -$113,433,392 (-324.47%) | -$26,723,607 (-134.08%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$80,650,172 (-103.23%) | -$39,684,056 (65.02%) | -$113,433,392 (-324.47%) | -$26,723,607 (-134.08%) |
Weighted Average Shares | $96,248,090 (71.06%) | $56,265,362 (7.11%) | $52,528,024 (11.37%) | $47,167,262 (1.81%) |
Weighted Average Shares Diluted | $96,248,090 (71.06%) | $56,265,362 (7.11%) | $52,528,024 (11.37%) | $47,167,262 (1.81%) |
Earning Before Interest & Taxes (EBIT) | -$79,638,850 (-103.66%) | -$39,103,712 (65.41%) | -$113,060,514 (-327.14%) | -$26,469,275 (-133.99%) |
Gross Profit | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Operating Income | -$81,639,296 (-111.74%) | -$38,556,891 (66.78%) | -$116,079,191 (-396.03%) | -$23,401,787 (-96.26%) |
RENB Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$1,260,179 (-4132.48%) | -$29,774 (-477.46%) | -$5,156 (89.45%) | -$48,892 (73.49%) |
Net Cash Flow from Financing | $10,517,455 (132.94%) | $4,515,056 (6.23%) | $4,250,464 (-86.96%) | $32,601,553 (352.80%) |
Net Cash Flow from Operations | -$10,971,430 (6.82%) | -$11,774,549 (25.16%) | -$15,732,336 (23.67%) | -$20,610,723 (-97.05%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$1,654,013 (77.34%) | -$7,297,662 (36.50%) | -$11,492,268 (-196.02%) | $11,968,049 (433.76%) |
Net Cash Flow - Business Acquisitions and Disposals | $65,851 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | -$1,255,600 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | -$70,430 (-136.55%) | -$29,774 (-477.46%) | -$5,156 (89.45%) | -$48,892 (73.49%) |
Issuance (Repayment) of Debt Securities | $7,175,590 (739.67%) | -$1,121,767 (-100.01%) | -$560,848 (-2.60%) | -$546,651 (-108.82%) |
Issuance (Purchase) of Equity Shares | $3,341,865 (-40.71%) | $5,636,823 (17.16%) | $4,811,312 (-85.49%) | $33,148,204 (3214.82%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $60,141 (816.39%) | -$8,395 (-60.21%) | -$5,240 (-120.07%) | $26,111 (118.39%) |
Share Based Compensation | $4,673,129 (32.19%) | $3,535,051 (-35.62%) | $5,490,602 (280.03%) | $1,444,798 (40.45%) |
Depreciation Amortization & Accretion | $121,859 (7.37%) | $113,496 (-8.17%) | $123,590 (0.05%) | $123,534 (-66.27%) |
RENB Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | - | - | - | - |
Profit Margin | - | - | - | - |
EBITDA Margin | - | - | - | - |
Return on Average Equity (ROAE) | -90.40% (-42.36%) | -63.50% (20.72%) | -80.10% (-397.52%) | -16.10% (-140.30%) |
Return on Average Assets (ROAA) | -70.60% (-33.71%) | -52.80% (26.46%) | -71.80% (-378.67%) | -15.00% (-134.37%) |
Return on Sales (ROS) | - | - | - | - |
Return on Invested Capital (ROIC) | 836.20% (-72.17%) | 3004.90% (214.95%) | -2614.10% (-757.08%) | -305.00% (-77.84%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -2.08 (-161.03%) | -0.8 (10.74%) | -0.89 (89.75%) | -8.72 (48.22%) |
Price to Sales Ratio (P/S) | - | - | - | - |
Price to Book Ratio (P/B) | 1.96 (175.49%) | 0.71 (-49.54%) | 1.41 (3.46%) | 1.36 (15.55%) |
Debt to Equity Ratio (D/E) | 0.24 (-7.09%) | 0.25 (53.94%) | 0.17 (91.86%) | 0.09 (21.13%) |
Earnings Per Share (EPS) | -0.84 (-18.31%) | -0.71 (67.13%) | -2.16 (-278.95%) | -0.57 (-128.00%) |
Sales Per Share (SPS) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Free Cash Flow Per Share (FCFPS) | -0.12 (45.24%) | -0.21 (30.00%) | -0.3 (31.51%) | -0.44 (-90.43%) |
Book Value Per Share (BVPS) | 1.37 (65.98%) | 0.83 (-40.23%) | 1.38 (-62.68%) | 3.7 (3.18%) |
Tangible Assets Book Value Per Share (TABVPS) | 0.04 (-45.07%) | 0.07 (-67.28%) | 0.22 (-55.62%) | 0.49 (95.60%) |
Enterprise Value Over EBIT (EV/EBIT) | -3 (-200.00%) | -1 (0.00%) | -1 (88.89%) | -9 (47.06%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -3.35 (-251.89%) | -0.95 (-9.30%) | -0.87 (90.45%) | -9.12 (48.10%) |
Asset Turnover | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Current Ratio | 0.07 (-71.67%) | 0.23 (-84.29%) | 1.48 (-86.62%) | 11.08 (65.43%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$11,041,860 (6.46%) | -$11,804,323 (24.99%) | -$15,737,492 (23.82%) | -$20,659,615 (-94.10%) |
Enterprise Value (EV) | $266,393,849 (617.81%) | $37,111,887 (-62.27%) | $98,358,551 (-59.07%) | $240,325,557 (24.92%) |
Earnings Before Tax (EBT) | -$80,650,172 (-103.23%) | -$39,684,056 (65.02%) | -$113,433,358 (-322.49%) | -$26,848,883 (-135.18%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$79,516,991 (-103.94%) | -$38,990,216 (65.48%) | -$112,936,924 (-328.67%) | -$26,345,741 (-140.69%) |
Invested Capital | -$22,974,200 (-597.56%) | -$3,293,502 (-218.87%) | $2,770,768 (-64.64%) | $7,835,873 (-14.02%) |
Working Capital | -$28,312,274 (-234.75%) | -$8,457,693 (-371.59%) | $3,114,170 (-83.62%) | $19,013,100 (149.96%) |
Tangible Asset Value | $3,769,246 (-6.01%) | $4,010,120 (-64.75%) | $11,377,395 (-50.69%) | $23,075,319 (99.60%) |
Market Capitalization | $258,133,652 (681.67%) | $33,023,483 (-67.69%) | $102,193,436 (-56.98%) | $237,545,881 (21.35%) |
Average Equity | $89,181,137 (42.77%) | $62,463,616 (-55.89%) | $141,613,990 (-14.58%) | $165,788,182 (-2.47%) |
Average Assets | $114,199,929 (52.08%) | $75,093,936 (-52.47%) | $157,983,533 (-11.16%) | $177,830,380 (-0.87%) |
Invested Capital Average | -$9,523,856 (-631.86%) | -$1,301,324 (-130.09%) | $4,324,970 (-50.17%) | $8,679,717 (31.56%) |
Shares | 147,504,944 (153.08%) | 58,283,591 (10.07%) | 52,949,967 (10.78%) | 47,795,952 (2.79%) |
